Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China flag China · Delayed Price · Currency is CNY
38.06
+0.04 (0.11%)
Sep 4, 2026, 3:00 PM CST

SHA:600211 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,9782,3271,6481,8601,140764.41
Trading Asset Securities
762.181,123976.62515.34792.49537.87
Cash & Short-Term Investments
3,7413,4502,6252,3751,9321,302
Cash Growth
23.58%31.44%10.51%22.92%48.38%66.22%
Accounts Receivable
854.95917.49732.82856.71625.68632.32
Other Receivables
30.8617.4411.8511.8212.6312.83
Receivables
885.81934.93744.67868.52638.31645.15
Inventory
194.86181.27134.19111.4399.95137.32
Prepaid Expenses
0.70.070.310.011.5-
Other Current Assets
73.6770.8965.9147.7740.0497.16
Total Current Assets
4,8964,6373,5703,4032,7122,182
Property, Plant & Equipment
633.38655.35669.85600.33551.38764.54
Long-Term Investments
382.81425.5132.94116.62129.75130.25
Goodwill
81.6884.018.888.888.888.88
Other Intangible Assets
274.72300.78184.09202.46416.48411.66
Long-Term Deferred Tax Assets
139.16132.52151.05115.4871.3467.16
Long-Term Deferred Charges
4.95.622.631.932.7947.69
Other Long-Term Assets
27.2226.327.99138.79206.96190.57
Total Assets
6,4406,2674,7474,5874,1003,803

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
44.0731.913.55.5114.3713.22
Accrued Expenses
386.82587.08377.65530.39412.7398.67
Short-Term Debt
1,150840.34272.17499.99486.1534.66
Current Portion of Leases
0.460.850.920.8812.13
Current Income Taxes Payable
43.3629.0325.545.3127.1322.13
Current Unearned Revenue
6.22.954.919.845.343.29
Other Current Liabilities
71.49147.9771.9292.5679.56135.56
Total Current Liabilities
1,7031,640766.571,1841,0261,110
Long-Term Debt
20.01-----
Long-Term Leases
0.060.150.31.131.141.86
Long-Term Unearned Revenue
26.9728.1127.3625.8527.5330.5
Long-Term Deferred Tax Liabilities
24.8225.4612.2914.0115.61
Other Long-Term Liabilities
440.83436.06----
Total Liabilities
2,2162,130795.231,2141,0691,158

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
322.32322.32322.32247.94247.94247.94
Additional Paid-In Capital
739.45752.21,1881,2631,2661,265
Retained Earnings
2,9942,6642,3301,7731,4551,169
Comprehensive Income & Other
35.7959.5177.5761.2142.98-51.42
Total Common Equity
3,9133,7983,9183,3453,0122,630
Minority Interest
310.48339.0534.2929.0319.0314.66
Shareholders' Equity
4,2244,1373,9523,3743,0312,645
Total Liabilities & Equity
6,4406,2674,7474,5874,1003,803

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,171841.34273.39501.99488.25538.65
Net Cash (Debt)
2,5702,6092,3511,8731,444763.63
Net Cash Growth
10.11%10.95%25.54%29.71%89.11%-1.22%
Net Cash Per Share
8.028.097.295.804.482.36
Filing Date Shares Outstanding
318.32322.32322.32322.32322.32322.32
Total Common Shares Outstanding
318.32322.32322.32322.32322.32322.32
Working Capital
3,1932,9972,8032,2181,6861,072
Book Value Per Share
12.2911.7812.1610.389.348.16
Tangible Book Value
3,5573,4143,7253,1332,5862,210
Tangible Book Value Per Share
11.1710.5911.569.728.026.86
Buildings
537.86535.52530.79462.4389.99439.89
Machinery
306.73309.36279.08446.34139.22159.08
Construction In Progress
40.8139.5365.0660.71153.6272.13